Total planned funding: $345,799,253
Clear active filters
FHI 360
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
Allocations
Countries/Regions
Mozambique | $73,311,736 |
South Africa | $45,090,757 |
Zimbabwe | $33,812,624 |
Asia Regional Program | $28,271,438 |
Zambia | $19,424,499 |
West Africa Region | $18,148,918 |
Tanzania | $17,524,488 |
Nigeria | $13,868,388 |
Burundi | $9,923,637 |
Botswana | $9,604,286 |
Kenya | $8,372,190 |
Democratic Republic of the Congo | $7,823,285 |
India | $7,814,357 |
Malawi | $7,667,705 |
Côte d'Ivoire | $7,109,567 |
Dominican Republic | $5,848,850 |
Indonesia | $4,976,794 |
Eswatini | $4,318,942 |
Vietnam | $4,141,176 |
Haiti | $2,616,452 |
Caribbean Region | $2,525,420 |
Papua New Guinea | $2,486,306 |
Angola | $2,466,719 |
Ethiopia | $2,324,111 |
Cambodia | $2,025,000 |
Uganda | $1,795,686 |
Lesotho | $1,638,960 |
South Sudan | $566,962 |
enumerations.Philippines | $300,000 |
Central Asia Region | $0 |
Organizational Types
NGO | $345,799,253 |
Program Areas
Treatment | $111,239,551 |
Prevention | $88,134,415 |
Care | $75,654,124 |
Testing | $44,684,166 |
Governance and Systems | $25,924,703 |
Management and Operations | $162,294 |
Budget Codes
HTXS: Treatment: Adult Treatment | $102,924,465 |
HVOP: Sexual Prevention: Other Sexual Prevention | $67,116,697 |
HKID: Care: Orphans and Vulnerable Children | $51,477,503 |
HVCT: Testing: HIV Testing and Counseling | $44,684,166 |
HBHC: Care: Adult Care and Support | $14,367,401 |
OHSS: Health Systems Strengthening | $12,994,358 |
HVAB: Sexual Prevention: Abstinence/Be Faithful | $10,346,395 |
HVSI: Strategic Information | $9,303,410 |
PDTX: Treatment: Pediatric Treatment | $8,315,086 |
PDCS: Care: Pediatric Care and Support | $6,364,292 |
MTCT: Biomedical Prevention: Prevention of Mother to Child Transmission | $5,385,711 |
HLAB: Laboratory Infrastructure | $3,626,935 |
HVTB: Care: TB/HIV | $3,444,928 |
CIRC: Biomedical Prevention: Voluntary Medical Male Circumcision | $2,426,933 |
IDUP: Prevention: Injecting and Non-Injecting Drug Use | $2,346,066 |
HMBL: Biomedical Prevention: Blood Safety | $334,929 |
HMIN: Biomedical Prevention: Injection Safety | $177,684 |
HVMS: Management and Operations | $162,294 |
HTXD: Treatment: ARV Drugs | $0 |